This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ISIS Pharmaceuticals Inc (ISIS)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 143.00M 159.97M 124.48M 65.48M
Receivables 3.90M 11.10M 522.00K 6.92M
Inventories 6.29M 8.03M 6.12M 4.14M
Other Current Assets 97.57M 59.61M 42.35M 5.42M
Total Current Assets 836.60M 735.51M 423.44M 360.14M
Property, Plant & Equipment, Gross 155.01M 146.63M 145.55M 144.04M
Accumulated Depreciation & Depletion 66.05M 60.43M 54.46M 47.42M
Property, Plant & Equipment, Net 88.96M 86.20M 91.08M 96.62M
Intangibles 19.88M 15.52M 18.65M 16.26M
Other Non-Current Assets 10.38M 9.93M 12.52M 11.88M
Total Non-Current Assets 119.21M 111.65M 122.25M 124.76M
Liabilities & Shareholder Equity
Total Assets 955.81M 847.16M 545.69M 484.89M
Accounts Payable 17.98M 11.01M 10.24M 8.30M
Short Term Debt 2.88M 4.41M 4.88M 3.39M
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 115.33M 97.81M 74.32M 76.11M
Long Term Debt 454.90M 77.83M 77.95M 215.45M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 127.80M 293.12M 210.65M 21.90M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 582.70M 370.95M 288.60M 237.35M
Total Liabilities 698.03M 468.77M 362.92M 313.46M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 257.78M 378.39M 182.77M 171.43M
Common Par 118.00K 116.00K 102.00K 100.00K
Additional Paid In Capital 1.22B 1.32B 1.08B 1.01B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -1.01B -967.61M -906.97M -841.49M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 39.75M 21.08M 12.48M -770.00K
Total Capitalization 712.68M 456.22M 260.72M 386.88M
Total Equity 257.78M 378.39M 182.77M 171.43M
Total Liabilities & Stock Equity 955.81M 847.16M 545.69M 484.89M
Total Common Shares Outstanding 118.44M 116.47M 101.48M 100.04M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 117.69M 110.50M 100.58M 99.66M
Diluted Weighted Shares Outstanding 117.69M 110.50M 100.58M 99.66M
Number of Employees 390 365 342 337
Number of Part-Time Employees 0 0 0 0

ISIS ISIS Pharmaceuticals Inc

Chart of ISIS

Analysts Ratings for ISIS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 2 2 2
Moderate Buy 1 1 1 1
Hold 5 5 5 5
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0

ISIS Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs